Company News - Press Releases - Events - Publications

Bicoll announces a new Advisory Board member – Dr. Michael Bogenstaetter officially appointed to join Bicoll’s Advisory Board

Munich, Germany – June 3, 2009 – The Bicoll GmbH, a biopharmaceutical company specializing in
high-tech natural product chemistry to identify novel small molecules for drug discovery and related
innovative fields, today announces the appointment of Dr. Michael Bogenstaetter as new member of
the Advisory Board. After a one year period of getting acquainted with Bicoll’s business model and
business segments, Dr. Bogenstaetter will now officially join the long-term advisors Dr. Hardy
Debuch, Prof. Dr. Thorsten Bach, Prof. Dr. Peter Vollhardt and Sina Afra.

Questions? Get in touch!

We would love talking to you:

Bicoll GmbH
Am Klopferspitz 19
82152 Planegg/Martinsried
+49 (0)89 820 106 30

This Site uses cookies, which could include third-party cookies, to ensure its technical functioning and which may contain tracking information about visitors. By continuing to browse this site you agree to our use of cookies. If you want to learn more about our Privacy Policy click here.